Skip to main content
Acta Crystallographica Section E: Structure Reports Online logoLink to Acta Crystallographica Section E: Structure Reports Online
. 2014 Oct 18;70(Pt 11):359–361. doi: 10.1107/S1600536814022417

Crystal structure of (R)-6′-bromo-3,3-dimethyl-3′,4′-di­hydro-2′H-spiro­[cyclo­hexane-1,3′-1,2,4-benzo­thia­diazine] 1′,1′-dioxide

P P Shinoj Kumar a, P A Suchetan b, S Sreenivasa a, S Naveen c, N K Lokanath d, D B Aruna Kumar a,*
PMCID: PMC4257282  PMID: 25484745

In the title compound, the mean plane of the cyclo­hexane ring is almost normal to the benzene ring and to the mean plane of the 1,2,4-thia­diazinane ring. In the crystal, mol­ecules are linked by N—H⋯O hydrogen bonds, forming chains along [10Inline graphic], which are in turn linked via C—H⋯π inter­actions, forming sheets parallel to (010).

Keywords: crystal structure, benzo­thia­diazine, hydrogen bonding, chirality

Abstract

In the title compound, C14H19BrN2O2S, the 1,2,4-thia­diazinane ring adopts an envelope conformation with the N atom (attached to the sulfonyl group) as the flap, while the cyclo­hexane ring adopts a chair conformation. The mean plane of the cyclo­hexane ring is almost normal to the benzene ring and the mean plane of the 1,2,4-thia­diazinane ring, making dihedral angles of 70.4 (2) and 71.43 (19)°, respectively. Furthermore, the dihedral angle between the benzene ring and the mean plane of the 1,2,4-thia­diazinane ring is 4.91 (18)°. The mol­ecular structure is stabilized by an intra­molecular C—H⋯O hydrogen bond, which encloses an S(6) ring motif. In the crystal, mol­ecules are linked by N—H⋯O hydrogen bonds into chains along [10-1], forming a C(6) graph-set motif. These chains are inter­connected via C—H⋯π inter­actions, leading to chains along [-101], so finally forming sheets parallel to (010).

Chemical context  

The sulfonamide class of drugs have been widely reported for their anti­bacterial and anti­fungal activities (Trujillo et al., 2009). 1,2,4-Benzo­thia­diazine 1,1-dioxides are used as anti­hypertensive, diuretic, anti­diabetic, glutamine­rgic neuro modulators (Cordi et al., 1996) and K-channel inhibitors (Di Bella et al., 1983). Furthermore, benzo­thia­diazine-3-one 1,1-dioxide and its derivatives have been reported for their potential hypoglycemic (Scozzafava et al., 2003), anti­cancer and anti-HIV activities (Casini et al., 2002), and they have also been reported to serve as selective antagonists of CXR2 (Hayao et al., 1968). In addition, 2-substituted-2H-1,2,4-benzo­thia­diazine-3(4H)one 1,1-dioxides have been found to exhibit varying degrees of sedative and hypotensive activities (Khelili et al., 2012). A number of benzo­thia­diazine 1,1-dioxide derivatives have recently been reported to display numerous biological activities (Tullio et al., 2011). graphic file with name e-70-00359-scheme1.jpg

In view of their broad spectrum of biological activities, and in a continuation of our work on this class of compound, we have synthesized the title compound, (1), and report herein on its spectroscopic analysis and crystal structure.

Structural commentary  

The mol­ecular structure of the title mol­ecule is shown in Fig. 1. The relative configuration of the asymmetric center is R for atom C7. The cyclo­hexane ring (C7–C12) adopts a chair conformation, confirmed by the puckering amplitude of Q = 0.4285 Å. The 1,2,4-thia­diazinane ring (N1/S1/C4/C3/N2/C7) adopts an envelope conformation with the flap atom N1 deviating by 0.565 (3) Å from the mean plane defined by atoms C7/N2/C3/C4/S1 [maximum deviation = 0.033 (1) Å for atom S1]. The mean plane of the cyclo­hexane ring is almost normal to the benzene ring (C1–C6) and the mean plane of the 1,2,4-thia­diazinane ring, making dihedral angles of 70.4 (2) and 71.43 (19)°, respectively. The dihedral angle between the benzene ring and the mean plane of the 1,2,4-thia­diazinane ring is 4.91 (18)°. The mol­ecular structure is stabilized by an intra­molecular C—H⋯O hydrogen bond, which forms an S(6) ring motif (Table 1 and Fig. 1).

Figure 1.

Figure 1

A view of the mol­ecular structure of the title mol­ecule, showing the atom labelling. Displacement ellipsoids are drawn at the 50% probability level. The C—H⋯O hydrogen bond is shown as a dashed line (see Table 1 for details).

Table 1. Hydrogen-bond geometry (, ).

Cg is the centroid of the C1C6 ring.

DHA DH HA D A DHA
C12H12AO1 0.97 2.40 3.066(5) 126
N2HN2O1i 0.86 2.26 3.101(5) 166
C11H11A Cg ii 0.97 2.58 3.506(5) 160

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

Supra­molecular features  

In the crystal, mol­ecules are linked by N—H⋯O hydrogen bonds (Table 1 and Fig. 2), forming chains with a C(6) graph-set motif along [10Inline graphic]. The chains are linked via structure-directing C—H⋯π inter­actions, leading to the formation of C(6) chains along [Inline graphic01]. These inter­actions lead to the formation of sheets parallel to (010) (Table 1 and Fig. 2).

Figure 2.

Figure 2

A view along the a axis of the crystal packing of the title compound. Hydrogen bonds are shown as thin blue lines (see Table 1 for details; H atoms not involved in hydrogen bonding have been omitted for clarity).

Database survey  

In two similar structures, namely 6-bromo-4H-spiro­[1,2,4-benzo­thia­diazine-3,1′-cyclo­butane] 1,1-dioxide, (2) (Shinoj Kumar, 2014a , and 6-bromo-1′-ethyl-4H-spiro­[1,2,4-benzo­thia­diazine-3,4′-piperidine] 1,1-dioxide, (3) (Shinoj Kumar, 2014b , the 1,2,4-thia­diazinane rings adopt a twisted chair conformation, in contrast to the envelope conformation observed in (1). In (2), the dihedral angle between the benzene ring and the mean plane of the cyclo­butyl ring is 73.76 (1)°, while that between the benzene ring and the mean plane of the 1,2,4-thia­diazinane ring is 4.72 (1)°, and that between the mean plane of the cyclo­butyl ring and the mean plane of the 1,2,4-thia­diazinane ring is 78.44 (1)°. In (3), the same dihedral angles are similar, being 73.61 (1), 6.73 (1) and 73.81 (1)°, respectively. These angles are also similar to those observed in the title compound, (1).

Synthesis and crystallization  

To a cooled solution of 2-amino-4-bromo­benzene sulfonamide (5 g, 19.9 mmol) and anhydrous magnesium sulfate (MgSO4; 3.5 g, 29.88 mmol) in dry toluene (60 ml), 3,3-di­methyl­cyclo­hexa­none (22 mmol) was added followed by slow addition of polyphospho­ric acid anhydride (T3P; 19 ml, 29.88 mmol, 50% solution in ethyl acetate). The reaction mixture was then refluxed in a sealed tube at 393 K for 6 h. It was cooled to 283 K and neutralized with saturated sodium bicarbonate solution (100 ml). The crude product was extracted with ethyl acetate (100 ml) and was finally washed with brine solution (50 ml). The organic phase was dried over anhydrous sodium sulfate and concentrated to give the crude product as a brown solid. It was then dissolved in a minimum amount of ethyl acetate (25 ml) and stirred for 1h in an ice-cooled bath, filtered and washed with cold ethyl acetate (10 ml × 2) to give pure compound (1) (4.5 g, 75% yield) as a white solid. Colourless prisms of the title compound were obtained by slow evaporation of a solution of the compound in ethyl acetate.

Spectroscopic characterization  

The IR spectra of the title compound exhibits strong bands at 1374 cm−1 due to asymmetric (S=O) stretching and a band at 1165 cm−1 due to symmetric (S=O) stretching. Further, a single band appearing at 3110 cm−1 is due to the secondary N—H group of the sulfonamide, and a band at 3308 cm−1 confirms the cyclization of sulfonamide through condensation with the ketone. Appearance of bands in the range of 2970–2815 cm−1 is assigned to the C—H stretching is due to the presence of the saturated hydro­carbons. The 1H NMR spectrum shows peaks at δ 7.53 (s, 1H, SO2NH), 6.934–6.930 (d, 1H, Ar-H), 7.37–7.35 (d, 1H, Ar-H), 3.33 (s, 1H, NH), 2.51–1.28 (m, 9H, CH2), 0.9–1.1 (s, 6H, CH3). The 13C NMR spectrum shows peaks at δ 144 (C1), 119 (C2), 126 (C3), 127 (C4), 119 (C5), 118 (C6), 117 (C7), 71 (C8), 47 (C9), 36 (C10), 33 (C11), 31 (C12), 18 (C13 and C14). The LC–MS spectrum shows the appearance of mol­ecular ion peaks at m/z 358 and 357 values, confirming the structure of the compound.

Refinement  

Crystal data, data collection and structure refinement details are summarized in Table 2. The NH hydrogens were located in a difference Fourier map. N- and C-bound H atoms were included in calculated positions (N—H = 0.86 and C—H = 0.93–0.97 Å) and allowed to ride on their parent atoms, with U iso(H) = 1.5U eq(C) for methyl H atoms and 1.2U eq(N,C) for other H atoms.

Table 2. Experimental details.

Crystal data
Chemical formula C14H19BrN2O2S
M r 359.28
Crystal system, space group Monoclinic, P21/n
Temperature (K) 293
a, b, c () 6.4316(7), 24.263(3), 10.0829(13)
() 105.604(9)
V (3) 1515.5(3)
Z 4
Radiation type Cu K
(mm1) 5.01
Crystal size (mm) 0.44 0.24 0.19
 
Data collection
Diffractometer Bruker APEXII
Absorption correction Multi-scan (SADABS; Bruker, 2009)
T min, T max 0.271, 0.386
No. of measured, independent and observed [I > 2(I)] reflections 11574, 2515, 1860
R int 0.081
(sin /)max (1) 0.586
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.049, 0.154, 0.94
No. of reflections 2515
No. of parameters 183
H-atom treatment H-atom parameters constrained
max, min (e 3) 0.61, 0.61

Computer programs: APEX2, SAINT-Plus and XPREP (Bruker, 2009), SHELXS97 and SHELXL97 (Sheldrick, 2008), andMercury (Macrae et al., 2008).

Supplementary Material

Crystal structure: contains datablock(s) 1, Global. DOI: 10.1107/S1600536814022417/su2797sup1.cif

e-70-00359-sup1.cif (24.1KB, cif)

Structure factors: contains datablock(s) 1. DOI: 10.1107/S1600536814022417/su27971sup2.hkl

e-70-00359-1sup2.hkl (121KB, hkl)

CCDC reference: 1028895

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors acknowledge the IOE X-ray diffractometer facility, University of Mysore, Mysore, for the data collection. PPSK, PAS, SS and DBAK are thankful to Tumkur University for providing the laboratory and instrumental facilities to carry out this work.

supplementary crystallographic information

Crystal data

C14H19BrN2O2S Dx = 1.575 Mg m3
Mr = 359.28 Melting point: 418 K
Monoclinic, P21/n Cu Kα radiation, λ = 1.54178 Å
a = 6.4316 (7) Å Cell parameters from 123 reflections
b = 24.263 (3) Å θ = 7.1–64.6°
c = 10.0829 (13) Å µ = 5.01 mm1
β = 105.604 (9)° T = 293 K
V = 1515.5 (3) Å3 Prism, colourless
Z = 4 0.44 × 0.24 × 0.19 mm
F(000) = 736

Data collection

Bruker APEXII diffractometer 1860 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tube Rint = 0.081
Graphite monochromator θmax = 64.6°, θmin = 7.1°
phi and φ scans h = −7→6
Absorption correction: multi-scan (SADABS; Bruker, 2009) k = −28→27
Tmin = 0.271, Tmax = 0.386 l = −11→11
11574 measured reflections 1 standard reflections every 1 reflections
2515 independent reflections intensity decay: 1%

Refinement

Refinement on F2 Primary atom site location: structure-invariant direct methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.049 Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.154 H-atom parameters constrained
S = 0.94 w = 1/[σ2(Fo2) + (0.1058P)2 + 0.1836P] where P = (Fo2 + 2Fc2)/3
2515 reflections (Δ/σ)max < 0.001
183 parameters Δρmax = 0.61 e Å3
0 restraints Δρmin = −0.61 e Å3

Special details

Experimental. Melting points were determined in open capillaries and are uncorrected. The molecular structures of the synthesized compounds were established using IR, 1H NMR, 13C NMR and LC-MS studies. Solid state FT-IR Spectra were recorded as KBr discs on Jasco FT-IR Spectrometer. 1H NMR and 13C NMR were recorded in DMSO at 399.13 MHz and 75.50 MHz respectively on Bruker model avance II. All the chemical shifts were reported in parts per million (ppm) using tetramethyl silane (TMS) as an internal standard. Mass spectra of the compounds were recordedon Shimadzu LC-2010EV with ESI probe.
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
C1 0.0489 (7) 0.09465 (19) 0.8681 (5) 0.0449 (11)
C2 0.0873 (7) 0.14863 (18) 0.8441 (4) 0.0398 (10)
H2 0.1873 0.1575 0.7959 0.048*
C3 −0.0244 (6) 0.19093 (16) 0.8922 (4) 0.0336 (9)
C4 −0.1634 (6) 0.17472 (17) 0.9715 (4) 0.0334 (9)
C5 −0.2014 (7) 0.11957 (18) 0.9908 (4) 0.0419 (10)
H5 −0.2992 0.1101 1.0401 0.050*
C6 −0.0993 (8) 0.07862 (19) 0.9394 (5) 0.0465 (11)
H6 −0.1275 0.0416 0.9514 0.056*
C7 −0.0697 (6) 0.29279 (16) 0.9203 (4) 0.0327 (9)
C8 −0.1071 (7) 0.33969 (17) 0.8148 (4) 0.0392 (10)
H8A −0.2288 0.3297 0.7384 0.047*
H8B 0.0186 0.3419 0.7792 0.047*
C9 −0.1502 (7) 0.39760 (18) 0.8637 (5) 0.0444 (11)
C10 0.0144 (8) 0.41054 (18) 1.0010 (5) 0.0491 (11)
H10A −0.0274 0.4444 1.0382 0.059*
H10B 0.1547 0.4165 0.9848 0.059*
C11 0.0326 (8) 0.36432 (19) 1.1071 (4) 0.0464 (11)
H11A 0.1388 0.3744 1.1918 0.056*
H11B −0.1053 0.3595 1.1277 0.056*
C12 0.0987 (6) 0.31045 (18) 1.0527 (4) 0.0378 (10)
H12A 0.1127 0.2819 1.1220 0.045*
H12B 0.2379 0.3150 1.0339 0.045*
C13 −0.3793 (8) 0.4038 (2) 0.8792 (6) 0.0579 (13)
H13A −0.3914 0.3838 0.9590 0.087*
H13B −0.4809 0.3893 0.7988 0.087*
H13C −0.4094 0.4420 0.8895 0.087*
C14 −0.1192 (10) 0.4391 (2) 0.7572 (6) 0.0657 (15)
H14A −0.1452 0.4756 0.7856 0.098*
H14B −0.2187 0.4311 0.6697 0.098*
H14C 0.0259 0.4366 0.7492 0.098*
N1 −0.2810 (5) 0.27879 (14) 0.9457 (3) 0.0342 (8)
HN1 −0.3930 0.2988 0.9117 0.041*
N2 0.0041 (5) 0.24419 (14) 0.8593 (4) 0.0373 (8)
HN2 0.0712 0.2499 0.7974 0.045*
O1 −0.1804 (5) 0.23557 (14) 1.1797 (3) 0.0442 (8)
O2 −0.5208 (4) 0.21181 (13) 1.0131 (3) 0.0469 (8)
S1 −0.29684 (15) 0.22511 (4) 1.03879 (10) 0.0352 (3)
Br1 0.20573 (10) 0.03945 (2) 0.80348 (7) 0.0701 (3)

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
C1 0.043 (3) 0.043 (3) 0.047 (3) −0.001 (2) 0.010 (2) −0.002 (2)
C2 0.041 (2) 0.038 (2) 0.044 (2) −0.0026 (19) 0.0185 (19) −0.0035 (18)
C3 0.035 (2) 0.031 (2) 0.033 (2) −0.0009 (17) 0.0070 (16) 0.0000 (16)
C4 0.032 (2) 0.040 (2) 0.030 (2) −0.0002 (17) 0.0097 (16) 0.0006 (16)
C5 0.048 (3) 0.045 (2) 0.036 (2) −0.002 (2) 0.0182 (19) 0.0046 (19)
C6 0.057 (3) 0.037 (2) 0.046 (3) −0.001 (2) 0.013 (2) 0.008 (2)
C7 0.030 (2) 0.034 (2) 0.035 (2) 0.0003 (17) 0.0117 (16) −0.0038 (16)
C8 0.046 (2) 0.041 (3) 0.032 (2) −0.006 (2) 0.0119 (18) −0.0009 (18)
C9 0.052 (3) 0.037 (2) 0.044 (3) −0.003 (2) 0.013 (2) 0.0022 (19)
C10 0.058 (3) 0.037 (3) 0.049 (3) −0.004 (2) 0.010 (2) −0.010 (2)
C11 0.050 (3) 0.048 (3) 0.034 (2) −0.002 (2) 0.0005 (19) −0.009 (2)
C12 0.030 (2) 0.043 (2) 0.037 (2) −0.0027 (18) 0.0044 (17) 0.0009 (18)
C13 0.049 (3) 0.055 (3) 0.067 (3) 0.014 (2) 0.009 (2) 0.001 (3)
C14 0.091 (4) 0.052 (3) 0.051 (3) 0.000 (3) 0.013 (3) 0.011 (2)
N1 0.0267 (16) 0.040 (2) 0.0370 (19) 0.0074 (14) 0.0098 (14) 0.0041 (15)
N2 0.0420 (19) 0.0343 (19) 0.044 (2) −0.0006 (15) 0.0265 (16) −0.0026 (15)
O1 0.0478 (18) 0.060 (2) 0.0258 (15) 0.0024 (15) 0.0112 (13) −0.0019 (13)
O2 0.0286 (15) 0.058 (2) 0.0562 (19) −0.0040 (14) 0.0153 (13) 0.0033 (15)
S1 0.0322 (5) 0.0435 (6) 0.0322 (6) 0.0004 (4) 0.0126 (4) 0.0007 (4)
Br1 0.0868 (5) 0.0414 (4) 0.0966 (6) 0.0091 (3) 0.0495 (4) −0.0070 (3)

Geometric parameters (Å, º)

C1—C2 1.366 (6) C9—C10 1.533 (6)
C1—C6 1.394 (6) C10—C11 1.533 (6)
C1—Br1 1.894 (5) C10—H10A 0.9700
C2—C3 1.412 (6) C10—H10B 0.9700
C2—H2 0.9300 C11—C12 1.522 (6)
C3—N2 1.359 (5) C11—H11A 0.9700
C3—C4 1.407 (5) C11—H11B 0.9700
C4—C5 1.383 (6) C12—H12A 0.9700
C4—S1 1.733 (4) C12—H12B 0.9700
C5—C6 1.368 (6) C13—H13A 0.9600
C5—H5 0.9300 C13—H13B 0.9600
C6—H6 0.9300 C13—H13C 0.9600
C7—N2 1.466 (5) C14—H14A 0.9600
C7—N1 1.489 (5) C14—H14B 0.9600
C7—C8 1.532 (6) C14—H14C 0.9600
C7—C12 1.537 (5) N1—S1 1.624 (3)
C8—C9 1.539 (6) N1—HN1 0.8600
C8—H8A 0.9700 N2—HN2 0.8600
C8—H8B 0.9700 O1—S1 1.439 (3)
C9—C13 1.530 (6) O2—S1 1.430 (3)
C9—C14 1.523 (6)
C2—C1—C6 122.7 (4) C9—C10—H10B 109.1
C2—C1—Br1 118.6 (3) C11—C10—H10B 109.1
C6—C1—Br1 118.8 (4) H10A—C10—H10B 107.8
C1—C2—C3 120.2 (4) C12—C11—C10 110.7 (4)
C1—C2—H2 119.9 C12—C11—H11A 109.5
C3—C2—H2 119.9 C10—C11—H11A 109.5
N2—C3—C2 119.5 (4) C12—C11—H11B 109.5
N2—C3—C4 123.6 (4) C10—C11—H11B 109.5
C2—C3—C4 116.9 (4) H11A—C11—H11B 108.1
C5—C4—C3 120.9 (4) C11—C12—C7 110.7 (3)
C5—C4—S1 120.2 (3) C11—C12—H12A 109.5
C3—C4—S1 118.8 (3) C7—C12—H12A 109.5
C6—C5—C4 121.9 (4) C11—C12—H12B 109.5
C6—C5—H5 119.0 C7—C12—H12B 109.5
C4—C5—H5 119.0 H12A—C12—H12B 108.1
C5—C6—C1 117.2 (4) C9—C13—H13A 109.5
C5—C6—H6 121.4 C9—C13—H13B 109.5
C1—C6—H6 121.4 H13A—C13—H13B 109.5
N2—C7—N1 107.6 (3) C9—C13—H13C 109.5
N2—C7—C8 108.3 (3) H13A—C13—H13C 109.5
N1—C7—C8 108.0 (3) H13B—C13—H13C 109.5
N2—C7—C12 110.9 (3) C9—C14—H14A 109.5
N1—C7—C12 112.1 (3) C9—C14—H14B 109.5
C8—C7—C12 109.8 (3) H14A—C14—H14B 109.5
C7—C8—C9 117.6 (3) C9—C14—H14C 109.5
C7—C8—H8A 107.9 H14A—C14—H14C 109.5
C9—C8—H8A 107.9 H14B—C14—H14C 109.5
C7—C8—H8B 107.9 C7—N1—S1 119.0 (3)
C9—C8—H8B 107.9 C7—N1—HN1 120.5
H8A—C8—H8B 107.2 S1—N1—HN1 120.5
C13—C9—C14 108.7 (4) C3—N2—C7 125.6 (3)
C13—C9—C10 109.8 (4) C3—N2—HN2 117.2
C14—C9—C10 108.2 (4) C7—N2—HN2 117.2
C13—C9—C8 112.6 (4) O2—S1—O1 116.72 (18)
C14—C9—C8 107.9 (4) O2—S1—N1 107.04 (18)
C10—C9—C8 109.6 (4) O1—S1—N1 109.40 (19)
C9—C10—C11 112.7 (4) O2—S1—C4 110.51 (19)
C9—C10—H10A 109.1 O1—S1—C4 109.26 (18)
C11—C10—H10A 109.1 N1—S1—C4 103.01 (17)
C6—C1—C2—C3 0.2 (7) C9—C10—C11—C12 58.9 (5)
Br1—C1—C2—C3 −179.2 (3) C10—C11—C12—C7 −60.5 (5)
C1—C2—C3—N2 −175.4 (4) N2—C7—C12—C11 173.9 (3)
C1—C2—C3—C4 3.8 (6) N1—C7—C12—C11 −65.8 (4)
N2—C3—C4—C5 173.8 (4) C8—C7—C12—C11 54.3 (4)
C2—C3—C4—C5 −5.3 (6) N2—C7—N1—S1 55.6 (4)
N2—C3—C4—S1 −3.3 (5) C8—C7—N1—S1 172.3 (3)
C2—C3—C4—S1 177.6 (3) C12—C7—N1—S1 −66.6 (4)
C3—C4—C5—C6 2.9 (6) C2—C3—N2—C7 −168.8 (4)
S1—C4—C5—C6 −180.0 (3) C4—C3—N2—C7 12.1 (6)
C4—C5—C6—C1 1.1 (7) N1—C7—N2—C3 −36.3 (5)
C2—C1—C6—C5 −2.7 (7) C8—C7—N2—C3 −152.8 (4)
Br1—C1—C6—C5 176.7 (3) C12—C7—N2—C3 86.6 (5)
N2—C7—C8—C9 −170.4 (3) C7—N1—S1—O2 −163.1 (3)
N1—C7—C8—C9 73.3 (4) C7—N1—S1—O1 69.6 (3)
C12—C7—C8—C9 −49.2 (5) C7—N1—S1—C4 −46.5 (3)
C7—C8—C9—C13 −75.8 (5) C5—C4—S1—O2 −44.6 (4)
C7—C8—C9—C14 164.3 (4) C3—C4—S1—O2 132.5 (3)
C7—C8—C9—C10 46.7 (5) C5—C4—S1—O1 85.1 (4)
C13—C9—C10—C11 74.3 (5) C3—C4—S1—O1 −97.7 (3)
C14—C9—C10—C11 −167.3 (4) C5—C4—S1—N1 −158.6 (3)
C8—C9—C10—C11 −49.9 (5) C3—C4—S1—N1 18.5 (3)

Hydrogen-bond geometry (Å, º)

Cg is the centroid of the C1–C6 ring.

D—H···A D—H H···A D···A D—H···A
C12—H12A···O1 0.97 2.40 3.066 (5) 126
N2—HN2···O1i 0.86 2.26 3.101 (5) 166
C11—H11A···Cgii 0.97 2.58 3.506 (5) 160

Symmetry codes: (i) x+1/2, −y+1/2, z−1/2; (ii) x+1/2, −y+1/2, z+1/2.

References

  1. Bruker (2009). APEX2, SADABS, SAINT-Plus and XPREP. Bruker AXS Inc., Madison, Wisconsin, USA.
  2. Casini, A., Scozzafava, A., Mastrolorenzo, A. & Supuran, C. (2002). Curr. Cancer Drug Targets, 2, 55–75. [DOI] [PubMed]
  3. Cordi, A., Spedding, M., Serkiz, B., Lepagnol, J., Desos, P. & Morain, P. (1996). Chem. Abstr. 124, 261085.
  4. Di Bella, M., Monzani, A., Andrisano, M. G., Fabio, U. & Quaglio, G. P. (1983). Farmaco, 38, 466–472.
  5. Hayao, S., Strycker, W. G., Phillips, B. & Fujimori, H. (1968). J. Med. Chem. 11, 1246–1248. [DOI] [PubMed]
  6. Khelili, S., Kihal, N., Yekhlef, M., de Tullio, P., Lebrun, P. & Pirotte, B. (2012). Eur. J. Med. Chem. 54, 873–878. [DOI] [PubMed]
  7. Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466–470.
  8. Scozzafava, A., Owa, T., Mastrolorenzo, A. & Supuran, C. T. (2003). Curr. Med. Chem. 10, 925–953. [DOI] [PubMed]
  9. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  10. Shinoj Kumar, P. P., Suchetan, P. A., Sreenivasa, S., Naveen, S., Lokanath, N. K. & Aruna Kumar, D. B. (2014a). Private communication (deposition number 1023519). CCDC, Cambridge, England.
  11. Shinoj Kumar, P. P., Suchetan, P. A., Sreenivasa, S., Naveen, S., Lokanath, N. K. & Aruna Kumar, D. B. (2014b). Private communication (deposition number 1023520). CCDC, Cambridge, England.
  12. Trujillo, J. I., Kiefer, J. R., Huang, W., Thorarensen, A., Xing, L., Caspers, N. L., Day, J. E., Mathis, K. J., Kretzmer, K. K., Reitz, B. A., Weinberg, R. A., Stegeman, R. A., Wrightstone, A., Christine, L., Compton, R. & Li, X. (2009). Bioorg. Med. Chem. Lett. 19, 908–911. [DOI] [PubMed]
  13. Tullio, P. de, Servais, A.-C., Fillet, M., Gillotin, F., Somers, F., Chiap, P., Lebrun, P. & Pirotte, B. (2011). J. Med. Chem. 54, 8353–8361. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) 1, Global. DOI: 10.1107/S1600536814022417/su2797sup1.cif

e-70-00359-sup1.cif (24.1KB, cif)

Structure factors: contains datablock(s) 1. DOI: 10.1107/S1600536814022417/su27971sup2.hkl

e-70-00359-1sup2.hkl (121KB, hkl)

CCDC reference: 1028895

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Structure Reports Online are provided here courtesy of International Union of Crystallography

RESOURCES